Trial Profile
Phase I study of AXP 1275 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Oct 2014
Price :
$35
*
At a glance
- Drugs AXP 1275 (Primary)
- Indications Allergic asthma
- Focus Adverse reactions
- 02 Oct 2014 New trial record